Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity
The findings of the current study provide valuable recommendations for enhancing immune infiltration and augmenting anti-tumor efficacy during chemotherapy in advanced NSCLC. In addition, the findings support "mitochondrial transfer" as a novel paradigm in tumor treatment.
Authors
- Bingjie Hao (ORCID: https://orcid.org/0000-0002-0799-9414)
- Shumeng Lin
- Shiyin Chen (ORCID: https://orcid.org/0009-0009-9127-7630)
- Xiaohong Chen (ORCID: https://orcid.org/0000-0002-9797-8384)
- Liuliu Yuan
- Lihong Fan (ORCID: https://orcid.org/0000-0002-7725-8128)
- Tiansheng Zheng (ORCID: https://orcid.org/0000-0002-1169-0225)
- Min Wei (ORCID: https://orcid.org/0000-0001-8848-5070)
Institutions
- Tongji University (CN)
- Nantong University (CN)
- Shanghai Tenth People's Hospital (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Cancer Biology and Medicine
- Published
- 2025-06-19
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2024.0596
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67